Back | Next |
home / stock / revb / revb message board
Subject | By | Source | When |
---|---|---|---|
Somebody has been loading here. | Lonewolf1 | investorshub | 01/27/2023 1:35:39 PM |
$REVBW: Warrants now at 0.0234 .......... hmmmmmmmmmmmmmm | makinezmoney | investorshub | 01/24/2023 8:12:42 PM |
OKAY U DA VETERANS. I GAVE U AN | frugallife | investorshub | 11/12/2022 9:29:26 PM |
time to short this stock because the website | frugallife | investorshub | 11/10/2022 11:24:05 PM |
I see you little girls i will wait | frugallife | investorshub | 11/10/2022 8:57:01 PM |
can yall bring it back down again thanks | frugallife | investorshub | 11/10/2022 4:59:43 PM |
QUICK 500 bucks not a brag but | frugallife | investorshub | 11/10/2022 3:04:21 PM |
easy money made when everyone is a sleep. | frugallife | investorshub | 11/10/2022 12:23:51 PM |
day two beings 19 great job ladies. | frugallife | investorshub | 11/10/2022 12:22:56 PM |
tomorrow starts day one. | frugallife | investorshub | 11/08/2022 10:17:43 PM |
Can this turn the tables? | ttottip | investorshub | 11/01/2022 2:00:04 PM |
This is going to regain most of today's | ttottip | investorshub | 10/26/2022 9:55:09 PM |
Interesting here. | ttottip | investorshub | 10/26/2022 7:07:48 PM |
znewcar1: $REVB 64% v71,4M c.411 f23,5M H.5014 ML.205 gap>3 and pushed to HOD choppy >.4 | znewcar1 | investorshangout | 10/25/2022 9:19:48 PM |
Revelation Biosciences Inc. Announces Positive Results in Preclinical | subslover | investorshub | 10/25/2022 1:56:05 PM |
Looks like this may have a couple up days. | kzivann | investorshub | 10/25/2022 1:23:52 PM |
Nice news. Nice move. | kzivann | investorshub | 10/25/2022 1:14:41 PM |
$REVB. up up and away! | subslover | investorshub | 10/25/2022 1:14:26 PM |
$REVB. up up and away! | subslover | investorshub | 10/25/2022 1:14:25 PM |
Drifted down. Bid filled. | kzivann | investorshub | 10/06/2022 5:58:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
OTCMKTS Market:
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March 31, ...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and twelve months ended...
– Prophylactic administration of Gemini (Intravenous PHAD®) reduces tissue damage and improves kidney function in a rat model of bilateral ischemic reperfusion induced acute kidney injury (AKI) - Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or ...